Search - tctmd.com

Displaying 21 - 40 of 70

Sort: Relevancy | Date

Presentation THT 2025

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Presenter: James Udelson

February 12, 2025

Presentation THT 2025

Adona Shunt: Adjustable Shunt With Built in Pressure Sensors

Presenter: Liviu Klein

February 12, 2025

Presentation THT 2025

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

Presenter: Sanjiv Shah

February 12, 2025

Presentation THT 2025

Interatrial Shunting for HF: Different Devices, Different Populations, Different Results

Presenter: Sheldon Litwin

February 12, 2025

Presentation THT 2025

INTERSHUNT: Leave No Device Behind

Presenter: Saibal Kar

February 12, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

Presentation THT 2024

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

Presenter: Firas Zahr

March 05, 2024

Presentation THT 2024

V-Wave: Final Thoughts Before the Big Reveal

Presenter: William T. Abraham

March 05, 2024

Presentation THT 2024

INTERSHUNT: Leave No Device Behind

Presenter: Saibal Kar

March 05, 2024

Presentation THT 2024

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Presenter: Javed Butler

March 05, 2024

Presentation THT 2024

Initial Trial Results With the Alleviant Shunt System

Presenter: James E. Udelson

March 05, 2024

Presentation THT 2024

Longitudinal Echocardiographic Changes in REDUCE-LAP II

Presenter: David M. Kaye

March 05, 2024

Presentation THT 2024

Patient Selection Considerations for Trials of Interatrial Shunts

Presenter: Sanjiv J. Shah

March 05, 2024

Presentation THT 2024

Left Atrial Pathophysiology: Why Shunts Should Help

Presenter: Greg Lewis

March 05, 2024

Advertisement

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Adona Shunt: Adjustable Shunt With Built in Pressure Sensors

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

Interatrial Shunting for HF: Different Devices, Different Populations, Different Results

INTERSHUNT: Leave No Device Behind

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

V-Wave: Final Thoughts Before the Big Reveal

INTERSHUNT: Leave No Device Behind

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Initial Trial Results With the Alleviant Shunt System

Longitudinal Echocardiographic Changes in REDUCE-LAP II

Patient Selection Considerations for Trials of Interatrial Shunts

Left Atrial Pathophysiology: Why Shunts Should Help

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content